EAST COAST EDITION: The evolving landscape of PSMA-targeted radioligand therapies in mCRPC
EVENT DETAILS
ACCREDITATION
Featured Speaker
Oliver Sartor
Moderator
Urban Emmenegger
Learning objectives:
- Summarize recent advances in mCRPC, focusing on treatment decision making and patient-centric approach to treatment.
- Discuss the place of 177LuPSMA-617 in mCRPC in the context of the wider treatment landscape.
- Share best practices regarding the implementation of PSMA-targeted RLT in a multi-disciplinary clinical practice.